Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-alpha agent with a disease-modifying antirheumatic drug?

Creative Commons License

ÜSKÜDAR CANSU D., Guncan S., Bilge N. S. Y., KAŞİFOĞLU T., KORKMAZ C.

EUROPEAN JOURNAL OF RHEUMATOLOGY, cilt.1, sa.2, ss.62-66, 2014 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 1 Sayı: 2
  • Basım Tarihi: 2014
  • Doi Numarası: 10.5152/eurjrheumatol.2014.019
  • Dergi Adı: EUROPEAN JOURNAL OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.62-66
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study is to determine the incidence of isoniazid (INH)-related hepatotoxicity in patients with rheumatologic diseases receiving tumor necrosis factor-alpha (TNF-alpha) antagonists along with a disease-modifying antirheumatic drug (DMARD).